Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine. 1992

T E Wilens, and J Biederman, and R J Baldessarini, and P R Puopolo, and J G Flood
Department of Psychiatry, Massachusetts General Hospital, Boston 02114.

Steady-state serum concentrations of desipramine (DMI) and its metabolite, 2-hydroxydesipramine (OHDMI), were measured in 40 children, 36 adolescents, and 27 adult psychiatric patients. The authors predicted that younger patients would show more efficient elimination of DMI, with greater amounts of OHDMI. OHDMI averaged 52% lower than DMI. DMI per weight-corrected dose (ng/mL: mg/kg) rose significantly with maturation, from 50 in children and 56 in adolescents to 91 in adults. Contrary to expectation, OHDMI per DMI dose also rose with age, from 17 in children and 20 in adolescents to 26 in adults. It was concluded that: (1) similar mg/kg doses of DMI result in lower DMI and OHDMI in children; (2) children metabolize both DMI and OHDMI more rapidly than adults; and (3) children do not have high circulating concentrations of OHDMI.

UI MeSH Term Description Entries
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003891 Desipramine A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. Desmethylimipramine,Apo-Desipramine,Demethylimipramine,Desipramine Hydrochloride,Norpramin,Novo-Desipramine,Nu-Desipramine,PMS-Desipramine,Pertofran,Pertofrane,Pertrofran,Petylyl,Ratio-Desipramine,Apo Desipramine,Hydrochloride, Desipramine,Novo Desipramine,Nu Desipramine,PMS Desipramine,Ratio Desipramine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

T E Wilens, and J Biederman, and R J Baldessarini, and P R Puopolo, and J G Flood
December 1986, The American journal of psychiatry,
T E Wilens, and J Biederman, and R J Baldessarini, and P R Puopolo, and J G Flood
October 1989, Clinical chemistry,
T E Wilens, and J Biederman, and R J Baldessarini, and P R Puopolo, and J G Flood
January 1992, Biological psychiatry,
T E Wilens, and J Biederman, and R J Baldessarini, and P R Puopolo, and J G Flood
September 1984, Clinical pharmacology and therapeutics,
T E Wilens, and J Biederman, and R J Baldessarini, and P R Puopolo, and J G Flood
February 1983, Clinical pharmacology and therapeutics,
T E Wilens, and J Biederman, and R J Baldessarini, and P R Puopolo, and J G Flood
April 1991, Journal of clinical psychopharmacology,
T E Wilens, and J Biederman, and R J Baldessarini, and P R Puopolo, and J G Flood
June 1986, The British journal of psychiatry : the journal of mental science,
T E Wilens, and J Biederman, and R J Baldessarini, and P R Puopolo, and J G Flood
April 1985, Archives of general psychiatry,
T E Wilens, and J Biederman, and R J Baldessarini, and P R Puopolo, and J G Flood
December 1996, International clinical psychopharmacology,
T E Wilens, and J Biederman, and R J Baldessarini, and P R Puopolo, and J G Flood
May 1995, Canadian journal of physiology and pharmacology,
Copied contents to your clipboard!